Monday, May 23, 2022
wellness India Expo
Home Tags Phase 3

Tag: Phase 3

First ever human patient dosed with Gene Therapy in Ocugen’s Phase...

This first patient dosing marks the beginning of the dose-escalating, observer-blind, Phase 1/2 safety and efficacy study

Phase-3 trial results show COVAXIN is 77.8% effective against symptomatic COVID-19

Efficacy analysis demonstrates COVAXIN to be 93.4% effective against severe symptomatic COVID-19. Efficacy data demonstrates 65.2% protection against the SARS-CoV-2, B.1.617.2 Delta variant..................................

COVAXIN demonstrates interim clinical efficacy of 78% in phase 3 trials

The second interim results showed India’s First COVID-19 Vaccine had demonstrated strong primary efficacy against severe COVID-19 disease.......................

Bharat Biotech’s COVAXIN Phase 3 results show interim clinical efficacy of...

Data from 25,800 participants that received the COVAXIN vaccine or placebo in a 1:1 ratio showed that the vaccine candidate was well-tolerated. It demonstrated 81% interim efficacy in preventing COVID-19 after the second dose....................

Serum Institute’s ROTASIIL shows great efficacy, included in national immunization program

The international nonprofit PATH partnered with Serum Institute of India to evaluate the vaccine which demonstrated significant efficacy against severe rotavirus gastroenteritis during its Phase 3 trials...........

Sun Pharma achieves breaking results for its Psoriasis drug

The company has achieved primary end point in both Phase-3 studies in patients with moderate-to-severe plaque Psoriasis...

Spain’s Almirall to commercialize Sun Pharma’s Psoriasis drug in Europe

Under terms of the license agreement, the Spanish firm, Almirall will pay Sun Pharma an initial upfront payment of $50 million for.....